Ignite Creation Date:
2025-12-24 @ 10:15 PM
Ignite Modification Date:
2026-01-05 @ 5:43 PM
Study NCT ID:
NCT05964335
Status:
COMPLETED
Last Update Posted:
2025-06-27
First Post:
2023-07-07
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Cough Reduction in IPF With Nalbuphine ER
Sponsor:
Trevi Therapeutics
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
NAL03-202
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None